This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bremberg, E. R. Articles by Eksborg, S. Search for Related Content PubMed PubMed Citation Articles by Bremberg, E. R. Articles by Eksborg, S. Social Bookmarking                         What's this?

An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital

Karolinska Pharmacy, Karolinska University Hospital, Stockholm, Sweden

Christina Hising, MD

Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

Urban Nylén, MD, PhD

Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

Hans Ehrsson, PhD

Karolinska Pharmacy, Karolinska University Hospital, Stockholm, Sweden

Staffan Eksborg, PhD

Karolinska Pharmacy, Karolinska University Hospital, Stockholm, Sweden

Aim. The aim of this project was to establish the importance of a pharmacist in the health-care team in improving drug use in an oncology ward in the Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.

Methods and patients. The pharmacist participated in the medical round in the mornings and worked as a member of the health-care team. Drug-related problems (DRPs) were identified by drug chart reviews based on data from medical files, laboratory tests and interviews with patients and/or relatives. A questionnaire to physicians and nurses was used to evaluate their experiences of the pharmacist’s contribution to the oncology ward.

Results. In total, 114 DRPs were identified in 58 patients. For each DRP, the pharmacist gave proposals for solutions. Sixty-eight suggestions out of 114 (59.6%) were implemented by the physician. Two suggestions (1.8%) were partly followed. For 32 suggestions (28.0%) it was unclear if they had caused any change in medication. Twelve suggestions (10.5%) were not followed. Most of the physicians and nurses acknowledged the pharmacist’s contribution to improved drug use in the ward.

Conclusion. A pharmacist can improve drug use in an oncology ward as a member of the health-care team. The pharmacist contributes with a systematic focus on the patient from a drug perspective.

Key Words: drug therapy • hospital • medication errors • multidisciplinary • oncology • pharmacy

Journal of Oncology Pharmacy Practice, Vol. 12, No. 2, 75-81 (2006)
DOI: 10.1177/1078155206070412


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Delaney, C. Chambers, G. Roldan, P. De Robles, G. Cairncross, P. Forsyth, and J. Easaw A feasibility study to assess the integration of a pharmacist into neurooncology clinic Journal of Oncology Pharmacy Practice, June 1, 2009; 15(2): 79 - 85. [Abstract] [PDF]

				S. Prot-Labarthe, R. Therrien, C. Demanche, D. Larocque, and J.-F. Bussieres Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service Journal of Oncology Pharmacy Practice, September 1, 2008; 14(3): 147 - 152. [Abstract] [PDF]